ProfileGDS4718 / 211406_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 59% 57% 58% 57% 55% 58% 57% 54% 46% 53% 54% 50% 58% 61% 69% 64% 65% 62% 63% 53% 49% 62% 57% 53% 59% 52% 61% 53% 56% 59% 51% 53% 53% 62% 53% 55% 56% 52% 59% 58% 55% 53% 56% 60% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.067659
GSM549102patient 115, normal, homogenized [OPG study]5.9453857
GSM549104patient 119, normal, homogenized [OPG study]6.0383358
GSM549108patient 138, normal, homogenized [OPG study]5.9876657
GSM549119patient 077, normal, homogenized [OPG study]5.8112555
GSM549133patient 032, cancer, homogenized [OPG study]5.9839358
GSM549139patient 042, cancer, homogenized [OPG study]5.9331257
GSM549099patient 107, normal, homogenized [OPG study]5.7301754
GSM549109patient 139, normal, homogenized [OPG study]5.3441346
GSM549110patient 046, normal, homogenized [OPG study]5.6904853
GSM549114patient 063, normal, homogenized [OPG study]5.7024854
GSM549122patient 082, normal, homogenized [OPG study]5.4930550
GSM549134patient 033, cancer, homogenized [OPG study]5.9840758
GSM549136patient 036, cancer, homogenized [OPG study]6.14561
GSM549140patient 044, cancer, homogenized [OPG study]6.8124269
GSM549111patient 047, normal, homogenized [OPG study]6.4255864
GSM549113patient 057, normal, homogenized [OPG study]6.4966465
GSM549132patient 031, cancer, homogenized [OPG study]6.244662
GSM549137patient 038, cancer, homogenized [OPG study]6.3372363
GSM549142patient 047, cancer, homogenized [OPG study]5.8357153
GSM549100patient 110, normal, homogenized [OPG study]5.4548749
GSM549107patient 135, normal, homogenized [OPG study]6.2600262
GSM549115patient 068, normal, homogenized [OPG study]5.9219757
GSM549116patient 072, normal, homogenized [OPG study]5.6751753
GSM549120patient 078, normal, homogenized [OPG study]6.0667659
GSM549131patient 030, cancer, homogenized [OPG study]5.565652
GSM549118patient 074, normal, homogenized [OPG study]6.1737861
GSM549129patient 027, cancer, homogenized [OPG study]5.7009753
GSM549123patient 088, normal, homogenized [OPG study]5.8833756
GSM549124patient 006, cancer, homogenized [OPG study]6.0494859
GSM549126patient 015, cancer, homogenized [OPG study]5.5543151
GSM549128patient 025, cancer, homogenized [OPG study]5.702553
GSM549103patient 117, normal, homogenized [OPG study]5.7252153
GSM549117patient 073, normal, homogenized [OPG study]6.2324362
GSM549138patient 041, cancer, homogenized [OPG study]5.7046153
GSM549141patient 045, cancer, homogenized [OPG study]5.7875755
GSM549130patient 028, cancer, homogenized [OPG study]5.8611556
GSM549101patient 111, normal, homogenized [OPG study]5.6847652
GSM549105patient 128, normal, homogenized [OPG study]6.0494559
GSM549106patient 134, normal, homogenized [OPG study]5.9402958
GSM549112patient 048, normal, homogenized [OPG study]5.8129655
GSM549125patient 011, cancer, homogenized [OPG study]5.7026853
GSM549127patient 024, cancer, homogenized [OPG study]5.9001856
GSM549135patient 035, cancer, homogenized [OPG study]6.14560